CDG Pharma

Building pharmaceutical
value across borders

US-based holding company focused on international pharmaceutical procurement and brand licensing for Latin American healthcare markets.

Get in touch
Pain management
Specialized in soft gel capsules formulations for analgesic and anti-inflammatory therapies.
Cardiometabolic
Bioequivalent cardiovascular and metabolic treatments for hypertension, diabetes, and related conditions, certified to developed-market standards.
Hospital & institutional
Broad coverage including injectables, chronic disease treatments, and biological medicines for private hospital and institutional healthcare programs.
10+
Years of experience
FDA
EMA
MHRA
Certified suppliers
Multiple markets
Across Latin America

Who we are

Our company

CDG Pharma is a pharmaceutical holding company incorporated in the United States. We focus on two core activities: sourcing pharmaceutical products from certified international manufacturers and managing a portfolio of proprietary pharmaceutical brands licensed across Latin America.

Our mission

We believe the affordability gap in emerging healthcare markets can be closed without compromising quality. Our approach is straightforward: build direct relationships with certified manufacturers, cut out unnecessary intermediaries, and pass that efficiency on to the markets we serve. The products in our portfolio meet the bioequivalence standards set by the FDA, EMA, and MHRA, so patients in developing regions get access to the same therapeutic outcomes available in the most regulated markets worldwide.

Our team

Our team has over ten years of hands-on experience in pharmaceutical procurement, regulatory processes, and commercial operations across emerging markets. We keep active commercial operations in the region through affiliated local partners who know their markets and their regulators.

What we do

Sourcing

International pharmaceutical procurement

We work with manufacturers in Asia whose facilities are approved by the FDA, EMA, and MHRA, as well as by Latin American regulatory authorities including INVIMA, DIGEMID, INHRR, and ARCSA. We manage the full cycle: supplier qualification, regulatory documentation, quality assurance, and logistics. Long-standing relationships with our manufacturing partners give us consistent supply and favorable terms that translate into competitive pricing for the markets we serve.

Licensing

Intellectual property & brand licensing

CDG Pharma owns a growing portfolio of registered pharmaceutical brands across multiple Latin American markets. We license these brands to qualified local operators who handle distribution and commercialization in their country. They bring the local knowledge and regulatory relationships; we bring the brands, the supplier network, and the quality oversight. It works because each side does what it does best.

Where we operate

We source from certified facilities in Asia and serve healthcare markets across Latin America. Two continents, one supply chain, zero compromise on quality.

Manufacturing partners

Certified production facilities in India with FDA, EMA, and MHRA approvals. Decades of manufacturing experience and export capability to over 100 countries.

Market presence

Active commercial operations across multiple Latin American markets through local affiliated partners with established distribution and regulatory networks.

Regulatory framework

Full CTD/eCTD dossier capability. Products developed to ICH guidelines for global regulatory submissions across multiple jurisdictions.

Let's talk

Whether you are a manufacturer looking to reach new markets, a distributor seeking reliable pharmaceutical supply, or a strategic partner exploring opportunities in emerging healthcare, we would like to hear from you.

info@cdgpharma.com